Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
ASH 2023: Study shows CAR-T cell therapy safe, effective even for high-risk patients
ASH 2023: Study shows CAR-T cell therapy safe, effective even for high-risk patients
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
ASH 2023: New drug helps narrow racial survival disparity in patients with acute myeloid leukaemia
ASH 2023: Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax
ASH 2023: Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk follicular lymphoma
ASH 2023: Combination immunotherapy produces high response rate in early results of trial targeting high-risk...
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment includes new drug quizartinib
ASH 2023: Patients with a common form of acute myeloid leukemia report better quality of life when treatment...
ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments
ASH 2023: Landscape for AML patients evolving rapidly as research discoveries advance new treatments
ASH 2023: Collaborators leads to new treatment options for advanced myelofibrosis, other blood malignancies
ASH 2023: Collaborators leads to new treatment options for advanced myelofibrosis, other blood malignancies
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Cell therapy appears safe and effective for lymphoma in remission
ASH 2023: Hodgkin lymphoma prognosis, biology tracked with circulating tumour DNA
ASH 2023: Hodgkin lymphoma prognosis, biology tracked with circulating tumour DNA
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia
ASH 2023: New personalised therapy improves survival for patients with CLL leukaemia

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation